Andrew T. Drechsler, Chief Financial Officer at Provention Bio, Inc. (PRVB), bought 6,250 shares at $4.00 ($25K) on 2018-07-19, disclosed to the SEC on 2018-07-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| INSM | SELL | 2017-03-03 | $660K | — | Filing → |
| INSM | SELL | 2016-11-15 | $660K | — | Filing → |
| VLRX | BUY | 2006-02-02 | $14K | — | Filing → |